WHO ICTRP trial
A Double Blind, Randomized, Placebo Controlled, Parallel Group, Dose-Titration…
EUCTR2007-007516-28-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-007516-28-DE |
|---|---|
| Public title | A Double Blind, Randomized, Placebo Controlled, Parallel Group, Dose-Titration Phase II Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Efficacy of an Anti-Angiotensin II Vaccine (CYT006-AngQb) in Patients with Mild to Moderate Essential Hypertension. |
| Scientific title | A Double Blind, Randomized, Placebo Controlled, Parallel Group, Dose-Titration Phase II Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Efficacy of an Anti-Angiotensin II Vaccine (CYT006-AngQb) in Patients with Mild to Moderate Essential Hypertension. |
| Primary sponsor | Cytos Biotechnology AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | Mild to moderate essential hypertension MedDRA version: 9.1 Level: LLT Classification code 10020772 Term: Hypertension |
| Interventions | Product Name: CYT006-AngQb Product Code: AngQb Pharmaceutical Form: Suspension for injection Current Sponsor code: CYT006-AngQb Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 0.6… |
| Registration date | Mar 14, 2008 |
| Target size | 80 |
| Secondary IDs | CYT006-AngQb 03 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: